Intranasal apomorphine in Parkinson's disease.
Kleedorfer
B
B
Department of Neurology, Middlesex Hospital, London, UK.
Turjanski
N
N
Ryan
R
R
Lees
A J
AJ
Milroy
C
C
Stern
G M
GM
D000281:Administration, Intranasal; D000368:Aged; D001058:Apomorphine / Q000008:administration & dosage* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007980:Levodopa / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D010300:Parkinson Disease / Q000188:drug therapy*; D010865:Pilot Projects
D007980:Levodopa; D001058:Apomorphine